During the past decade, IKF Pneumologie GmbH & Co. KG conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 15 clinical trials were completed, i.e. on average, 68.2% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 13 clinical trials were completed. i.e. 130% of trials that started reached the finish line.

Out of the total clinical trials conducted in "IKF Pneumologie GmbH & Co. KG" #1 sponsor was "Boehringer Ingelheim" with 11 trials, followed by "BioNTech SE" with 4 trials sponsored, "Pfizer" with 4 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "AbbVie" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "IKF Pneumologie GmbH & Co. KG" #1 collaborator was "Eli Lilly and Company" with 3 trials as a collaborator, "Pfizer" with 3 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator, "FGK Clinical Research GmbH" with 1 trials as a collaborator and "German Federal Ministry of Education and Research" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "IKF Pneumologie GmbH & Co. KG" are "Pulmonary Disease, Chronic Obstructive" (5 trials), "Asthma" (3 trials), "COVID-19" (3 trials), "COPD" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "IKF Pneumologie GmbH & Co. KG" in a lesser frequency.

Most popular intervention types in "IKF Pneumologie GmbH & Co. KG" are "Drug" (21 trials), "Biological" (4 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "BNT162b2" (4 trials), "Empagliflozin" (2 trials), "Olodaterol" (2 trials) and "Tiotropium" (2 trials). Other intervention names were less common.

The vast majority of trials in "IKF Pneumologie GmbH & Co. KG" are 26 trials for "All" genders.

Currently, there are NaN active trials in "IKF Pneumologie GmbH & Co. KG". undefined are not yet recruiting, 2 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in IKF Pneumologie GmbH & Co. KG, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in IKF Pneumologie GmbH & Co. KG, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".

IKF Pneumologie GmbH & Co. KG has several departments that took part in Clinical trials: "IKF Pneumologie GmbH & Co. KG Am Standort IFS - Interdisziplinäres Facharztzentrum" - 3 trials, "IKF Pneumologie Mainz Helix Medical Excellence Center Mainz" - 2 trials